Smileyscope received $4.1 million funding acording to the SEC form registered.
The document is a Form D filing submitted to the US Securities and Exchange Commission by Amalgam Rx, a healthcare technology company. The filing indicates that Amalgam Rx has raised $17,365,000 USD through the issuance of equity securities to an undisclosed group of investors. The funds raised will be used for working capital and general corporate purposes.
Azumio, the maker of the diabetes management solution GlucoseBuddy, registered a SEC form stating $916,000 funding from the investors.
Rimidi received $1.3 million from the investors according to the SEC form registered.
Welldoc registered a SEC form stating the funding of $4.2 million from the investors.
San Francisco-based FareWell has raised $8.5 million for an online program aimed at preventing chronic diseases by addressing obesity as a root cause. The funding comes from individual investors including David Perry, the company's cofounder and chairman.
One Drop received $6.1 million from the investors in an equity round according to the SEC file registered.
Amalgam Rx received $1.2 million in an equity round from the investors according to the SEC file registered.
The £500,000 investment comes from a number of backers, including 500 Startups — an American venture capital firm, Bethnal Green Ventures — an accelerator for start-ups with a social purpose, and private angels.
Thrive365 received $835,000 funding from the investors in an equity round according to the SEC file registered.